Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

EDIT

Editas Medicine Inc

May 08 • 04:00PM ET

3.11

+0.08 2.64 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: PRME NTLA BEAM CRSP SANA

| Held by: VTI IWM VXF IWN IBB SCHA VTWO IWC VHT SCHB

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.22	Insider Own	0.51%	Shs Outstand	97.87M	Perf Week	7.24%
Market Cap	304.49M	Forward P/E	-	EPS next Y	-0.93	Insider Trans	-2.61%	Shs Float	97.41M	Perf Month	7.61%
Enterprise Value	252.81M	PEG	-	EPS next Q	-0.26	Inst Own	51.43%	Short Float	11.21%	Perf Quarter	70.88%
Income	-108.95M	P/S	7.87	EPS this Y	45.21%	Inst Trans	7.73%	Short Ratio	6.80	Perf Half Y	11.87%
Sales	38.69M	P/B	69.05	EPS next Y	5.26%	ROA	-52.76%	Short Interest	10.92M	Perf YTD	51.71%
Book/sh	0.05	P/C	2.46	EPS next 5Y	16.42%	ROE	-326.07%	52W High	4.54 -31.46%	Perf Year	123.74%
Cash/sh	1.26	P/FCF	-	EPS past 3/5Y	17.49% 1.84%	ROIC	-175.22%	52W Low	1.29 141.09%	Perf 3Y	-67.67%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	27.15% -14.89%	Gross Margin	90.07%	Volatility	7.16% 8.14%	Perf 5Y	-90.88%
Dividend TTM	-	EV/Sales	6.53	EPS Y/Y TTM	59.82%	Oper. Margin	-230.09%	ATR (14)	0.23	Perf 10Y	-89.68%
Dividend Ex-Date	-	Quick Ratio	3.22	Sales Y/Y TTM	7.97%	Profit Margin	-281.59%	RSI (14)	54.82	Recom	2.17
Dividend Gr. 3/5Y	- -	Current Ratio	3.22	EPS Q/Q	72.14%	SMA20	-1.50%	Beta	2.14	Target Price	5.73
Payout	-	Debt/Eq	16.32	Sales Q/Q	-39.22%	SMA50	14.50%	Rel Volume	0.69	Prev Close	3.03
Employees	87	LT Debt/Eq	13.10	Earnings	May 05 BMO	SMA200	17.52%	Avg Volume	1.61M	Price	3.11
IPO	Feb 03, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.14% -55.58%	Trades		Volume	1,114,769	Change	2.64%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)